Home > PJ (Current issue) > FIP Congress 2006 | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 (Supplement) F15
October 2006

This article
Reprint   Photocopy

PDF 30K, Acrobat Reader

Meetings

See FIP Reports

FIP Congress 2006

Imogen Savage reports from a Community Pharmacy Section session on managing change in pharmacy practice

World Congress of Pharmacy and Pharmaceutical Sciences The World Congress of Pharmacy and Pharmaceutical Sciences, the 66th International FIP Congress, was organised by the International Pharmaceutical Federation in association with the Federal Council of Pharmacy of Brazil.
It took place in Salvador da Bahia from August 26 to 31, 2006

Schools should “train revolutionaries”

ARTICLE CONTENTS
Schools should “train revolutionaries”

Progress in Finland

Challenge in Germany

Uruguay: “now at least we have a boat”

If the pharmacy profession wants change, then it must “train revolutionaries”, Christine Nimmo, of the American Society of Health-System Pharmacists, told the congress.

Listening to her joint presentation with Ross Holland, of PharmEd Consultants, US, the audience heard that changing the public and professional mindset on what makes a “good pharmacist” is a vital part of managing change. If pharmacy wants change, then professional organisations need to be influencing the views and expectations of potential future pharmacists through vocational guidance given to schools and by working to change undergraduate admissions criteria to schools of pharmacy.

Dr Nimmo explained that the dominant personality type in pharmacy is someone with a strong sense of responsibility, who is conscientious, practical and logical but not extrovert or “social”. Research had shown that one in five pharmacists has a fear of verbal communication.

For change to happen, some people will need “attitude readjustment”, and this is where national pharmacy associations can help, by shifting public perception of the qualities that make a good pharmacist and motivating corporations and pharmacy owners to believe that change is both desirable and doable.

The ability to communicate effectively is important because changing practice is much more than “just doing it”, for example, by creating new posts or writing new job descriptions. The first step is to work on what society needs, and consider the practice environment in the context of the wider health care system.

“We don’t exist in a cocoon, a vacuum; we interact with society,” Dr Nimmo said. So to make change happen, pharmacists need to influence both the public view and the views of other health professions. The profession needs to “get on their [stakeholders’] playing field” and use research to show that patients are not getting optimal care under the present system.

For health systems with third party payers, it is critically important to show that health care costs go down when pharmacists work in collaboration with other health care providers. This will be key to achieving a mechanism for payment for new services, she said.

Making change happen also needs what Dr Nimmo and Dr Holland called a “conducive practice environment” with the time and physical space for staff to take on new roles, plus relevant, high quality training. This needs leadership from pharmacy owners. They have to be clear on staff training needs, but should not be afraid to use national pharmacy organisations and schools of pharmacy to deliver continuing education programmes.

Progress in Finland

In Finland the TIPPA project has changed public perception of pharmacy but the process has taken “20 years of blood sweat and tears”, said Eeva Terasalmi, from Apple Pharmacy, Virkkala. “You must have a strong wish for what you want to have.”

The project, managed by the Association of Finnish Pharmacists, started in the 1980s at a time when community pharmacy was becoming increasingly vulnerable. The aim was to develop a professional concept for pharmacists and pharmacies and to promote a quality public health service. Their strategy had included lobbying, publications to promote key pharmacy activities, continuing education programmes for pharmacy staff and a change in basic education in schools.

Ms Terasalmi said that it is not just older practitioners who have to be involved in the change process. “We have to give a clear view to newcomers and educate them to challenge the old ways of working in pharmacies,” she said.

The pharmacy undergraduate curriculum had been designed in 1994; the next year a “quality pays” programme was launched. In 1998 ethical codes specific to community practice had been published. A key aim was for the public to understand the pharmacist’s role as part of the local health care team, and booklets on topics such as the pharmacists’ ethical code of practice and their role in self-medication and health promotion had been widely circulated to decision-makers.

Ms Terasalmi said there has been a big change in public perceptions over the past 10 years. The first national survey on consumer expectations had been done in 1988, five years after pharmacists had first been given “the duty to counsel”. Then, privacy had been the major concern for the public. The project has subsequently worked on promoting pharmacist’s role in self-medication.

By 2001, 65 per cent of pharmacies had in-house guidelines for patient counselling, and more than half were collaborating with other local health care providers on a regular basis. Their second consumer survey, in 2001 gave a clear message that the public wanted these practice developments to continue.

She warned that to maintain change, every pharmacist has to accept the need to change, and actually make the change. “It’s a cycle of change and we have to accept it is slow.”

Challenge in Germany

Martin Schultz, from the centre for drug information and pharmacy practice at Frankfurt University, Germany, said the shift from product to patient orientation is still proving to be a challenge for the profession.

Non-adherence to medication offers a “big role” for community pharmacy and is relatively easy to tackle as part of pharmacist’s duties as a drugs expert. However progress worldwide has been “disappointing”. This he suggested is because of lack of willingness to change, from politicians and payers down to pharmacy staff.

“We have to change, just staying as we are will not secure community pharmacy,” Professor Schultz told the meeting. That means focusing on factors that facilitate change, not the barriers to it.

Uruguay: “now at least we have a boat”

Eduardo Savio, from the University of the Republic, Uruguay, described the rapid changes that are taking place in his country after it had been proposed as a pilot “good pharmacy practice” site in March 2005.

He told the meeting that in previous years he had thought there was a “gap like an ocean” between pharmacy practice in his country and elsewhere. “Now we feel at least we have a boat,” he said.

With 1,250 pharmacies, half of which are located in the capital city, there is huge competition and a split between city and countryside practice. There is a 40:60 split between private health care cover and public health care services, and private clinics and hospitals account for 50 per cent of drug distribution. Hospitals have much greater buying power than community pharmacies, and can negotiate better prices for drugs. There is much competition for patients, and no incentives to invest in staff.

A survey of pharmacists and health organisations, authorities and hospitals, found a significant lack of awareness of current pharmacy regulations. These did not require a pharmacist to be present in the pharmacy, but 40 per cent of practising pharmacists and 80 per cent of administrators did not know this.

The first step for the project taskforce had been to improve the legal framework and to develop national professional standards for good dispensing practice, self-medication and rational drug use. The undergraduate curriculum is being redesigned to introduce more therapeutics and a greater patient focus, and a continuing education programme for pharmacy owners and pharmacy assistants has already been piloted.

Professor Savio said that participant feedback had been encouraging but change is a multifactorial process and they are at “the start of a very long road”.


©The Pharmaceutical Journal